| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Mrz―05 |
Scaffolds of biologically active heterocyclic compounds for discovery of potential drug against SARS-CoV-2 |
Archana R. Patil, Basappa C. Yallur, Geetika Pant, Eliza Ahmed, S.G. Prasanna Kumar, Sheetal R. Batakurki, Anjanapura V. Raghu |
| 2 |
[GO] |
2024―Okt―10 |
Synthesis, confirmation based on in vitro and in silico study of thiadiazole-based thiazolidinone scaffolds: An approach toward Covid-19 |
Shoaib Khan, Rafaqat Hussain, Yousaf Khan, Tayyiaba Iqbal, Mohammad Shahidul Islam, Tahani Mazyad Almutairi |
| 3 |
[GO] |
2024―Aug―03 |
Synthesis, characterization, cytotoxicity, and antiviral activity of new coumarin analogues against coronavirus |
Mohammad Auwal Sa’ad, Manickam Ravichandran, Lalitha Pattabhiraman, Shivkanya Fuloria, Veerasamy Ravichandran, Faizul Fikri Mohd Yusop, Neeraj Kumar Fuloria |
| 4 |
[GO] |
2024―Jul―14 |
Synthesis, in vitro and in silico studies of pyrazole analogs as SARS-CoV-2 inhibitors |
Sandeep Singh, Yu-Cheng Chu, Rajeev Kumar Sharma, Po-Huang Liang, R. Ramajayam |
| 5 |
[GO] |
2024―Mrz―28 |
Quantum chemical characterization and molecular docking analysis of Hydroxychloroquine on noble Metal-Loaded silica nano Composites: Implications for COVID-19 drug discovery |
G.F. Nivetha, V. Vetrivelan, T. Nithiyanandham, Alpaslan Bayrakdar, S. Muthu, M. Prasath |
| 6 |
[GO] |
2024―Mrz―11 |
Noncovalent SARS-COV-2 main protease inhibitors: A virtual screening and molecular dynamic simulation study |
Aoxiang Yan, Wei Li, Xu Zhao, Ruiyuan Cao, Hua Li, Lixia Chen, Xingzhou Li |
| 7 |
[GO] |
2023―Okt―04 |
Chitosan-based pulmonary particulate systems for anti-cancer and antiviral drug carriers: A promising delivery for COVID-19 vaccines |
Bushra Tousian, Ali Reza Khosravi |
| 8 |
[GO] |
2023―Sep―27 |
Computer-aided design, syntheses, and ITC binding data of novel flavanone derivatives for use as potential inhibitors of the papain-like protease of COVID-19 |
Anna J. Sigmon, Eleanora Margulis, Christy George, Tatiana N. Laremore, Hamzah Al-Quaid, Julia Fecko, Neela H. Yennawar |
| 9 |
[GO] |
2023―Sep―09 |
Adsorption behavior, different green solvent effect and surface enhanced Raman spectra (SERS) investigation on inhibition of SARS-CoV-2 by antineoplastic drug Carmofur with silver/gold/platinum loaded silica nanocomposites: A combined computational analysis and molecular modelling approach |
G.F. Nivetha, V. Vetrivelan, S. Muthu, M. Prasath |
| 10 |
[GO] |
2023―Sep―04 |
Synthesis, DFT, ADME and Docking Studies of Homoegonol and Egonol as Potential Inhibitors of COVID-19 Main Protease (6LU7) |
Tummuri Sudheer Reddy, Karreddula Raja, K.N. Teja reddy, M.S. Surendra Babu |
| 11 |
[GO] |
2023―Jun―27 |
A sensitive UPLC-MS/MS method for the simultaneous assay and trace level genotoxic impurities quantification of SARS-CoV-2 inhibitor-Molnupiravir in its pure and formulation dosage forms using fractional factorial design |
Srinivas Nakka, Siva Krishna Muchakayala, Surendra Babu Manabolu Surya |
| 12 |
[GO] |
2022―Nov―07 |
Microwave-assisted synthesis of (6-((1-(4-aminophenyl)-1H-1,2,3-triazol-4-yl)methoxy)substituted benzofuran-2-yl)(phenyl)methanones, evaluation of in vitro anticancer, antimicrobial activities and molecular docking on COVID-19 |
Ravinder Dharavath, M. Sarasija, K.N. Prathima, M. Ram Reddy, Shyam Panga, Vishnu Thumma, D. Ashok |
| 13 |
[GO] |
2022―Mrz―16 |
Characterization, molecular modeling and pharmacology of some 2́-hydroxychalcone derivatives as SARS-CoV-2 inhibitor |
Mohammad Nasir Uddin, Sayeda Samina Ahmed, Monir Uzzaman, Md. Nazmul Hassan Knock, Wahhida Shumi, Abul Fazal Md. Sanaullah, Mosharef Hossain Bhuyain |
| 14 |
[GO] |
2021―Dez―12 |
2-Phenoxyacetamide Derivatives as SARS-CoV-2 Main Protease Inhibitor: In Silico Studies |
Pandu Hariyono, Rini Dwiastuti, Muhammad Yusuf, Nurul H. Salin, Maywan Hariono |
| 15 |
[GO] |
2021―Dez―09 |
Structural modification of antineoplastic drug carmofur designed to the inhibition of SARS-CoV-2 main protease: A theoretical investigation |
Niloofar Hemati, Saba Hadidi, Farshad Shiri, Mohammad Hosein Farzaei |
| 16 |
[GO] |
2021―Okt―09 |
Development of a spectroscopic technique that enables the saliva based detection of COVID-19 at safe distances |
Jijo Lukose, Ajayakumar Barik, V.K. Unnikrishnan, Sajan D. George, V.B. Kartha, Santhosh Chidangil |
| 17 |
[GO] |
2021―Sep―29 |
In silico investigation of phytoconstituents of medicinal herb ‘Piper Longum’ against SARS-CoV-2 by molecular docking and molecular dynamics analysis |
Shradha Lakhera, Kamal Devlal, Arabinda Ghosh, Meenakshi Rana |
| 18 |
[GO] |
2021―Sep―20 |
Potential SARS-CoV-2 3CLpro inhibitors from chromene, flavonoid and hydroxamic acid compound based on FRET assay, docking and pharmacophore studies |
Maywan Hariono, Pandu Hariyono, Rini Dwiastuti, Wahyuning Setyani, Muhammad Yusuf, Nurul Salin, Habibah Wahab |
| 19 |
[GO] |
2021―Jun―12 |
Molecular basis of quercetin as a plausible common denominator of macrophage-cholesterol-fenofibrate dependent potential COVID-19 treatment axis |
Anil Pawar, Amit Pal, Kalyan Goswami, Rosanna Squitti, Mauro Rongiolettie |
| 20 |
[GO] |
2021―Mai―06 |
A Concise Discussion on the Potential Spectral Tools for the Rapid COVID-19 Diagnosis |
Abhijeet Mohanty, Adarsh P. Fatrekar, Saravanan Krishnan, Amit A. Vernekar |
| 21 |
[GO] |
2021―Apr―22 |
Triazole, imidazole, and thiazole-based compounds as potential agents against coronavirus |
Insa Seck, Filomain Nguemo |
| 22 |
[GO] |
2020―Dez―28 |
In-silico drug repurposing study: Amprenavir, enalaprilat, and plerixafor, potential drugs for destabilizing the SARS-CoV-2 S-protein-angiotensin-converting enzyme 2 complex |
Ivonne Buitrón-González, Giovanny Aguilera-Durán, Antonio Romo-Mancillas |
